New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Diabetes drug could influence brain activity in Alzheimer's

Diabetes drug could influence brain activity in Alzheimer's

by Alzheimer's Research UKResearchers in Denmark have released findings from a small clinical trial of the diabetes drug liraglutide in people living with Alzheimer's disease.Thepil
Neurology February 28,2024
Diabetes drug could influence brain activity in Alzheimer's

Diabetes drug could influence brain activity in Alzheimer's

by Alzheimer's Research UKResearchers in Denmark have released findings from a small clinical trial of the diabetes drug liraglutide in people living with Alzheimer's disease.Thepil
Neurology February 28,2024
Investigating plasma levels as a biomarker for Alzheimer's disease

Investigating plasma levels as a biomarker for Alzheimer's disease

by Bentham Science PublishersA Centre for Healthy Brain Ageing (CHeBA) paper published inCurrent Alzheimer Researchpresents the first detailed study of the relationship between plasma leve
Neurology February 28,2024
Investigating plasma levels as a biomarker for Alzheimer's disease

Investigating plasma levels as a biomarker for Alzheimer's disease

by Bentham Science PublishersA Centre for Healthy Brain Ageing (CHeBA) paper published inCurrent Alzheimer Researchpresents the first detailed study of the relationship between plasma leve
Neurology February 28,2024
Drug discovery paradigm targets Tau protein aggregation linked to the Alzheimer's disease

Drug discovery paradigm targets Tau protein aggregation linked to the Alzheimer's disease

by Bentham Science PublishersDementia and other tauopathies, most notably Alzheimer's disease, embody a class of neurodegenerative diseases associated with the aggregation of the Tau protein in th
Neurology February 28,2024
Drug discovery paradigm targets Tau protein aggregation linked to the Alzheimer's disease

Drug discovery paradigm targets Tau protein aggregation linked to the Alzheimer's disease

by Bentham Science PublishersDementia and other tauopathies, most notably Alzheimer's disease, embody a class of neurodegenerative diseases associated with the aggregation of the Tau protein in th
Neurology February 28,2024
Eli Lilly changes outcome goals in Alzheimer's drug study

Eli Lilly changes outcome goals in Alzheimer's drug study

by Linda A. JohnsonEli Lilly said Tuesday that it's changed the outcome goals for a late-stage patient study of its closely watched experimental drug for Alzheimer's disease, solanezumab.The E
Neurology February 28,2024
Eli Lilly changes outcome goals in Alzheimer's drug study

Eli Lilly changes outcome goals in Alzheimer's drug study

by Linda A. JohnsonEli Lilly said Tuesday that it's changed the outcome goals for a late-stage patient study of its closely watched experimental drug for Alzheimer's disease, solanezumab.The E
Neurology February 28,2024
Is dementia on the decline? Research suggests it might be

Is dementia on the decline? Research suggests it might be

by Allie Shah, Star Tribune (Minneapolis)Despite fears that the coming silver tsunami will trigger a dementia epidemic, a surprising new study suggests that it may be possible to delay - or even preve
Neurology February 28,2024
Is dementia on the decline? Research suggests it might be

Is dementia on the decline? Research suggests it might be

by Allie Shah, Star Tribune (Minneapolis)Despite fears that the coming silver tsunami will trigger a dementia epidemic, a surprising new study suggests that it may be possible to delay - or even preve
Neurology February 28,2024
Antidepressant use begins years before Alzheimer's diagnosis

Antidepressant use begins years before Alzheimer's diagnosis

by University of Eastern FinlandAntidepressants are frequently prescribed to persons with Alzheimer's disease before the diagnosis, according to a recent study from the University of Eastern
Neurology February 28,2024
Antidepressant use begins years before Alzheimer's diagnosis

Antidepressant use begins years before Alzheimer's diagnosis

by University of Eastern FinlandAntidepressants are frequently prescribed to persons with Alzheimer's disease before the diagnosis, according to a recent study from the University of Eastern
Neurology February 28,2024
Adolescent perspectives on mental health benefits and risks associated with TikTok use

Adolescent perspectives on mental health benefits and risks associated with TikTok use

by American Pediatric SocietyCredit: Unsplash/CC0 Public DomainA new study examines adolescent perspectives on mental health benefits and risks associated with TikTok use. Findings from the study
Pediatrics February 28,2024
Adolescent perspectives on mental health benefits and risks associated with TikTok use

Adolescent perspectives on mental health benefits and risks associated with TikTok use

by American Pediatric SocietyCredit: Unsplash/CC0 Public DomainA new study examines adolescent perspectives on mental health benefits and risks associated with TikTok use. Findings from the study
Pediatrics February 28,2024
Giant tube slides and broken legs: Why the latest playground craze is a serious hazard

Giant tube slides and broken legs: Why the latest playground craze is a serious hazard

by Lisa Nicole Sharwood, David Eager and Ruth Barker,The ConversationCredit: LeProz from PexelsChild's play involves risk and challenge, a vital part of development. Failing, falling and pic
Pediatrics February 28,2024
Giant tube slides and broken legs: Why the latest playground craze is a serious hazard

Giant tube slides and broken legs: Why the latest playground craze is a serious hazard

by Lisa Nicole Sharwood, David Eager and Ruth Barker,The ConversationCredit: LeProz from PexelsChild's play involves risk and challenge, a vital part of development. Failing, falling and pic
Pediatrics February 28,2024
Some children with cerebral palsy scoliosis may not need pelvic fixation, study shows

Some children with cerebral palsy scoliosis may not need pelvic fixation, study shows

by University of MichiganCredit: Pixabay/CC0 Public DomainA new Michigan Medicine study finds that some children with cerebral palsy and scoliosis do not require pelvic fixation when undergoing g
Pediatrics February 28,2024
Some children with cerebral palsy scoliosis may not need pelvic fixation, study shows

Some children with cerebral palsy scoliosis may not need pelvic fixation, study shows

by University of MichiganCredit: Pixabay/CC0 Public DomainA new Michigan Medicine study finds that some children with cerebral palsy and scoliosis do not require pelvic fixation when undergoing g
Pediatrics February 28,2024
Swedish children with migration backgrounds less likely to receive recommended psychiatric treatment, study shows

Swedish children with migration backgrounds less likely to receive recommended psychiatric treatment, study shows

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainChildren with migration backgrounds in Sweden are less likely than other children to receive recommended treatment for psychiatric diagnos
Pediatrics February 28,2024
Swedish children with migration backgrounds less likely to receive recommended psychiatric treatment, study shows

Swedish children with migration backgrounds less likely to receive recommended psychiatric treatment, study shows

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainChildren with migration backgrounds in Sweden are less likely than other children to receive recommended treatment for psychiatric diagnos
Pediatrics February 28,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com